Mrv0541 04191212102D 28 29 0 0 1 0 999 V2000 6.9269 -17.7973 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 6.9269 -18.6223 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 6.2124 -17.3848 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 6.2124 -19.0348 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 5.4979 -17.7973 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 5.4979 -18.6223 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 7.6414 -17.3848 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 8.3558 -17.7973 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 7.6414 -16.5598 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 9.0703 -17.3848 0.0000 C 0 0 2 0 0 0 0 0 0 0 0 0 9.7848 -17.7973 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 9.0703 -16.5598 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 9.7848 -16.1473 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 9.7848 -15.3222 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 10.4993 -16.5598 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 10.4994 -14.9097 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 11.2138 -16.1473 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 11.2138 -15.3222 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 9.7848 -18.6223 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 10.4993 -17.3848 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 11.2138 -17.7973 0.0000 C 0 0 1 0 0 0 0 0 0 0 0 0 11.9282 -17.3848 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 12.6427 -17.7973 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 13.3572 -17.3848 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 12.6427 -18.6223 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 11.2138 -18.6223 0.0000 B 0 0 0 0 0 0 0 0 0 0 0 0 10.4993 -19.0348 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 11.9282 -19.0348 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 2 1 1 0 0 0 0 3 1 2 0 0 0 0 4 2 2 0 0 0 0 5 3 1 0 0 0 0 6 4 1 0 0 0 0 6 5 2 0 0 0 0 1 7 1 0 0 0 0 7 8 1 0 0 0 0 7 9 2 0 0 0 0 10 8 1 1 0 0 0 10 11 1 0 0 0 0 10 12 1 0 0 0 0 14 13 1 0 0 0 0 15 13 2 0 0 0 0 16 14 2 0 0 0 0 17 15 1 0 0 0 0 18 16 1 0 0 0 0 18 17 2 0 0 0 0 12 13 1 0 0 0 0 11 19 2 0 0 0 0 11 20 1 0 0 0 0 20 21 1 0 0 0 0 21 22 1 0 0 0 0 22 23 1 0 0 0 0 23 24 1 0 0 0 0 23 25 1 0 0 0 0 21 26 1 1 0 0 0 26 27 1 0 0 0 0 26 28 1 0 0 0 0 M END > DB00188 > drugbank > CC(C)C[C@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)C1=CN=CC=N1)B(O)O > InChI=1S/C19H25BN4O4/c1-13(2)10-17(20(27)28)24-18(25)15(11-14-6-4-3-5-7-14)23-19(26)16-12-21-8-9-22-16/h3-9,12-13,15,17,27-28H,10-11H2,1-2H3,(H,23,26)(H,24,25)/t15-,17-/m0/s1 > GXJABQQUPOEUTA-RDJZCZTQSA-N > C19H25BN4O4 > 384.237 > 384.196885774 > 6 > 53 > -0.022249573444512668 > 40.65072235381561 > 1 > 4 > 0 > 1 > [(1R)-3-methyl-1-[(2S)-3-phenyl-2-[(pyrazin-2-yl)formamido]propanamido]butyl]boronic acid > 0.89 > 1.5303000000000004 > -3.86 > 0 > 0 > 2 > 0 > 12.935952423377957 > 8.642948571164315 > -0.585841951334518 > 124.44000000000001 > 99.37379999999999 > 9 > 1 > 5.32e-02 g/l > tetrahydrofolic acid > 0 > DB00188 > APRD00828; DB07475 > approved; investigational > Bortezomib > [(1R)-3-methyl-1-({(2S)-3-phenyl-2-[(pyrazin-2-ylcarbonyl)amino]propanoyl}amino)butyl]boronic acid; Bortezomib; N-[(1R)-1-(DIHYDROXYBORYL)-3-methylbutyl]-N-(pyrazin-2-ylcarbonyl)-L-phenylalaninamide > Bortezomib; Bortezomib Accord; Bortezomib Fresenius Kabi; Bortezomib Hospira; Bortezomib Sun; Velcade $$$$